Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 350

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

326. A Versatile Tool for Conditional Gene Expression and Knockdown

Open access
Szulc, Jolanta, Wiznerowicz, Maciej, Beermann, Friedrich, Trono, Didier, Aebischer, Patrick·2006·Molecular Therapy

Abstract

Drug-inducible systems allowing the control of gene expression in mammalian cells are invaluable tools for genetic research, and could also fulfill essential roles in gene- and cell-based therapy. However, currently available systems often exhibit limited in vivo functionality due to leakiness, insufficient levels of induction, lack of tissue specificity or prohibitively complicated designs. To overcome these limitations we have developed a lentivector-based, conditional gene expression system for tetracycline-controllable repression of polymerase II-driven transgenes or polymerase III- controlled sequences encoding small inhibitory hairpin RNAs (shRNAs). Our system allows for tightly controlled, robust, and fully reversible gene expression or knockdown in cell lines, primary human haemopoietic progenitor cells and embryonic mouse stem cells (ES) in vitro, in both Tet-on or Tet-off configurations. Tight and efficient conditional expression of human Glial Cell Line Derived Neurotrophic Factor (GDNF) in the rat striatum and substantia nigra was achieved using this vector offering numerous opportunities for gene therapy approaches, modeling human diseases or studying gene function in central nervous system. When used for conditional knockdown this system allows for robust and fully reversible control of endogenous TP53 tumor supressor in human cancer cells xenotransplanted into nude mice, thus opening promising possibilities for both basic and applied cancer research. Finally, we probed the potential of our system by generating transgenic mice either by infection of fertilized oocytes with LV vectors or blastocyst transfer of transduced ES cells. These results pave the novel ways for basic or translational research, the development of gene-based therapeutics, and for creation of animal models of human diseases. M.W. and D.T. patented part of the technology described in this article.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2006.08.383

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 350

Metadata

Authors
Szulc, J., Wiznerowicz, M., Beermann, F., Trono, D., & Aebischer, P.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2006
Volume
13
Issue
2
Pages
S124
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2022501852
Cited by
350
References
2
FWCI
24.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 326. A Versatile Tool for Conditional Gene Expression and Knockdown. https://app.cochat.ai/papers/10.1016/j.ymthe.2006.08.383
The paper
Szulc, J., Wiznerowicz, M., Beermann, F., Trono, D., & Aebischer, P. (2006). 326. A Versatile Tool for Conditional Gene Expression and Knockdown. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2006.08.383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.